API Pharmaceutical intermediate Drug impurity Inhibitor
Nanjing Yuanzhida Pharmaceutical Technology Co., Ltd
Country: China (Mainland)
Business Type: Lab/Research institutions
4-HYDROXY-3-BETA-D-RIBOFURANOSYL-1H-PYRAZOLE-5-CARBOXAMIDE MONOHYDRATECAS NO.: 30868-30-5
7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 5-[4-[2,6-difluoro-4-(2-methoxyethoxy)phenyl]-1-piperazinyl]-3,6-dihydro-3-methyl-CAS NO.: 1858179-75-5
L-Glutamic acid,N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-,1-(1,1-dimethylethyl) esterCAS NO.: 79640-70-3
6-(3-methoxyphenyl)-3-(pyridin-3-yl)pyrazolo[1,5-a]pyrimidin-7-amineCAS NO.: 861249-59-4
methyl (S)-2-((2-(2,6-difluoro-4-(4-methylcarbamoyl)phenyl)-7-methylimidazo[1,2-a]pyridin-3-yl)methyl)morpholine-4-carboxylateCAS NO.: 1621164-74-6